HEALTHPREMIUM TIMES NIGERIA
Fidson dominates Nigeria’s Pharma sector first-quarter 2026
Fidson dominates Nigeria’s pharmaceutical sector in the first-quarter 2026. Population growth, urbanisation, and rising healthcare awareness are driving increased demand for medicines in Nigeria.
Mentioned
Related Signal
Adjacent reporting
- FG to commission 11 pharmaceutical manufacturing projects in 2026 to boost local drug production
- Haleon introduces new corporate identity in Nigeria, partners with Fidson
- Drug maker Fidson posts 28% jump in half-year profit
- Fidson PLC donates theatre pharmacy to FMC Asaba
- Nigeria’s Capital Inflows Nearly Double to $10.37 Billion — But Most Is Hot Money
- Nigeria targets expanded MMS coverage for pregnant women, seeks shift from donor dependency